SAGE-547 drug found to be effective in the management of Postpartum Depression

 

Emobileclinic Researchers’Corner

 

 

An experimental drug touted as a breakthrough for treating severe postpartum depression has been discovered by Sage Therapeutics in a small clinical trial study which shows some promising results.It was reported recently that 7 of the 10 women who took the drug in the trial experienced significant improvement in their depression within 60 hours of the injection.

That effect was maintained for 30 days. Out of 11 women who took the placebo, just one experienced remission within 60 hours. Interestingly, none of the patients who took the drug reported psychiatric side effects, such as abnormal dreams, insomnia, and anxiety — but 5 of the 11 women on the placebo reported such symptoms. A few patients in each group experienced dizziness or a sedative effect.It is important to know that the Sage drug is designed to change the traffic patterns in the brain. There is a natural push and pull between neurotransmitters called NMDA receptors and the GABA receptors that regulate their flow in the brain. In cases of severe depression, that equilibrium gets out of whack, and Sage’s drug is meant to restore it, modulating those GABA receptors to allow NMDA to do its job.
The study is small and has not been peer-reviewed; Sage disclosed the results in a press release. The company has not submitted study data to federal regulators and isn’t at this point seeking approval of the drug, known as SAGE-547, for postpartum depression. Its next steps: expanding the trial to enroll more women and to determine optimum doses.

READ  Molecular flexibility found useful with pharmaceutical drugs to treat varying diseases

According to Jonas, women in the trial were asked not to breastfeed for the first 10 days after receiving the injection. The drug has a “very, very short half-life” in the body; this means that it can be metabolized quickly.
Though preliminary, the early results on postpartum depression are tantalizing. One of the drug’s most promising features: It appears to work quickly — some women in the study started experiencing relief after 24 hours. By contrast, traditional antidepressants can take weeks to begin working. The only other treatment for postpartum depression is talk therapy.SAGE-547’s apparent speed is what is getting the most attention in the psychiatric community, Baker said. In the early days of motherhood, women ideally build competency and confidence in their parenting. Dealing with postpartum depression derails that process, and it’s linked to increased rates of anxiety and mood disorders among children, she said.

A serious mood disorder that affects as many as 1 in 7 women after childbirth, postpartum depression can lead to panic attacks, inconsolable sadness, and deep feelings of inadequacy. Some women have thoughts of harming their baby or themselves.



Leave a Reply